Index : Keywords
Liste des classifications (clusters par fréquence et par distance de cosinus):
Les termes de plus forte occurence
669 | Humans |
408 | Female |
326 | Male |
292 | Human |
247 | Middle Aged |
220 | Adult |
193 | Aged |
145 | Treatment |
132 | Prognosis |
108 | Mutation |
107 | Adolescent |
105 | Treatment Outcome |
94 | Animals |
93 | Child |
85 | Young Adult |
82 | Epidemiology |
82 | Chemotherapy |
80 | Comparative study |
79 | Risk Factors |
77 | Cancerology |
76 | Genotype |
73 | Genetics |
70 | Risk factor |
70 | Phenotype |
70 | Antineoplastic agent |
69 | Medicine |
66 | Genetic Predisposition to Disease |
64 | Aged, 80 and over |
62 | Polymorphism, Single Nucleotide |
60 | Genome-Wide Association Study |
59 | Public health |
59 | Case-Control Studies |
57 | Clinical trial |
50 | Time Factors |
48 | Risk |
48 | Malignant tumor |
48 | Ecosystem |
48 | Breast Neoplasms (genetics) |
47 | Models |
47 | Luminosity |
46 | Genet |
45 | Other hand |
45 | International |
44 | Galaxies |
43 | Syndrome |
43 | Patient |
43 | Infant |
43 | Ecology |
43 | Child, Preschool |
43 | Cardiology |
42 | Toxicity |
42 | Phys |
42 | Modeling |
39 | Randomization |
39 | Centre |
38 | Double-Blind Method |
38 | Baseline |
38 | Advanced stage |
37 | Cardiovascular disease |
36 | Circulatory system |
35 | Review |
35 | Nervous system diseases |
35 | Mnras |
35 | Follow-Up Studies |
35 | Europe |
35 | Biodiversity |
34 | Disease-Free Survival |
34 | Climate change |
34 | Breast cancer |
34 | Age Factors |
33 | Phase III trial |
33 | Global |
33 | Gene |
32 | Simulation |
32 | Retrospective Studies |
32 | Photometry |
32 | Cohort Studies |
32 | Clinical trials |
31 | Red giant stars |
31 | Metallicity |
31 | Database |
31 | Blackwell publishing |
30 | Treatment efficiency |
30 | Rheumatology |
30 | Prospective Studies |
30 | Prevalence |
30 | Neurology |
30 | Mortality |
30 | Locus |
29 | Radial velocity |
29 | Good agreement |
29 | Geophys |
29 | Cohort |
29 | AIDS |
28 | Polymorphism, Single Nucleotide (genetics) |
28 | Galaxy |
28 | Fracture |
28 | Evolution |
28 | Clin |
28 | Age |
27 | Wide range |
27 | Uncertainty |
27 | Severity of Illness Index |
27 | Recommendation |
27 | Practice Guidelines as Topic |
27 | Medical genetics |
27 | Incidence |
27 | European Continental Ancestry Group (genetics) |
27 | Dynamics |
27 | Data sets |
27 | Algorithm |
27 | Acute |
26 | Recurrence |
26 | Journal compilation |
26 | Guideline |
26 | Chem |
26 | Australia |
26 | Allele |
25 | Star formation |
25 | Milky Way |
25 | Lett |
25 | Consensus |
24 | Survival Rate |
24 | Reproducibility of Results |
24 | Relapse |
24 | Mice |
24 | Local group |
24 | John wiley sons |
24 | Galaxy evolution |
24 | Disease Progression |
24 | Coronary heart disease |
24 | Coronary artery |
24 | Complication |
24 | Antiviral |
24 | Anomaly |
23 | Variability |
23 | Stellar |
23 | Standard deviation |
23 | Risk factors |
23 | Present study |
23 | Phylogeny |
23 | Neoplasm Staging |
23 | Modelling |
23 | Inhibitor |
23 | Global Health |
23 | Genetic Predisposition to Disease (genetics) |
23 | Dwarf galaxies |
22 | Surveys and Questionnaires |
22 | Proportional Hazards Models |
22 | Odds Ratio |
22 | National institute |
22 | Median |
22 | Kinematics |
22 | International Cooperation |
22 | Galaxy formation |
22 | Diabetes mellitus |
22 | Cognition |
22 | Case study |
22 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
21 | World |
21 | Star clusters |
21 | Prevention |
21 | Pregnancy |
21 | Metastasis |
21 | Isotope |
21 | Heterogeneity |
21 | Genome |
21 | Genetic Variation |
21 | Canada |
21 | Blood pressure |
21 | Biol |
21 | Assay |
21 | Alleles |
20 | Randomized |
20 | Quality of Life |
20 | Present address |
20 | Placebo |
20 | Osteoporosis |
20 | Myocardial infarction |
20 | Morphology |
20 | Kaplan-Meier Estimate |
20 | Immunomodulator |
20 | Halo |
20 | Giant stars |
20 | Drug Therapy, Combination |
20 | Chromosome |
20 | Breast Neoplasms (pathology) |
20 | Astroseismology |
19 | Tumour |
19 | Total number |
19 | Stellar mass |
19 | Risk Assessment |
19 | Previous studies |
19 | Methodology |
19 | Matrix |
19 | Large number |
19 | Evidence-Based Medicine |
19 | Elderly |
19 | Defect |
19 | Data analysis |
19 | Carbon dioxide |
18 | Variant |
18 | Variance |
18 | Symptomatology |
18 | Survival |
18 | Spectroscopy |
18 | Solid line |
18 | Resistance |
18 | Registries |
18 | Receptor |
18 | Radiotherapy |
18 | Ovarian Neoplasms (genetics) |
18 | Ndings |
18 | Internationality |
18 | Hypertension |
18 | Graft |
18 | Evaluation |
18 | Drug Administration Schedule |
18 | Dos |
18 | Deletion |
18 | Color |
18 | Chromosome Mapping |
18 | British columbia |
18 | Antibiotic |
18 | Algorithms |
17 | Spectroscopic |
17 | Second cancer |
17 | Renal failure |
17 | Red shift |
17 | Prostate cancer |
17 | Programme |
17 | Polymorphism |
17 | Metaanalysis |
17 | Marine environment |
17 | Light curves |
17 | Infection |
17 | Infant, Newborn |
17 | Hong kong |
17 | Heart failure |
17 | Globular clusters |
17 | Genetic Association Studies |
17 | Family history |
17 | Ecological |
17 | Diagnosis |
17 | Chronic |
17 | Cardiac |
17 | Cancer |
17 | Antineoplastic Agents (therapeutic use) |
17 | Abnormality |
16 | University hospital |
16 | Treatment groups |
16 | Transplantation |
16 | Susceptibility |
16 | Surveillance |
16 | Subgroup |
16 | Spatial distribution |
16 | Sequence Analysis, DNA |
16 | Renal |
16 | Pathway |
16 | Lung cancer |
16 | Lesion |
16 | Immunosuppressive agent |
16 | Imaging |
16 | Galaxy clusters |
16 | Exon |
16 | Alzheimer disease |
15 | Velocity dispersion |
15 | Time series |
15 | Stellar evolution |
15 | Software |
15 | Same time |
15 | Recent years |
15 | Precipitation |
15 | Multicenter study |
15 | Molecular Sequence Data |
15 | Missense |
15 | Malignant melanoma |
15 | Laser |
15 | Kidney |
15 | Human genetics |
15 | High levels |
15 | Grid |
15 | Galaxy structure |
15 | Error bars |
15 | Environment |
15 | Dysfunction |
15 | Drug combination |
15 | Disease Management |
15 | Dark matter |
15 | Case control study |
15 | Carcinoma |
15 | Cambridge university press |
15 | Body Mass Index |
15 | Biopsy |
15 | Asthma |
15 | Adverse events |
14 | World health organization |
14 | Woman |
14 | Surgery |
14 | Register |
14 | Randomized Controlled Trials as Topic |
14 | Neurol |
14 | Missense mutations |
14 | Metabolism |
14 | Intravenous administration |
14 | Impairment |
14 | Human mutation |
14 | Hematology |
14 | Haplotype |
14 | Galactic |
14 | Enzyme inhibitor |
14 | Environ |
14 | Disk galaxies |
14 | Data points |
14 | Czech republic |
14 | Cross-Sectional Studies |
14 | Clinical management |
14 | Climate models |
14 | Bottom panel |
13 | Zonal |
13 | Western australia |
13 | Tidal |
13 | Systematic review |
13 | Survival Analysis |
13 | Statistical analysis |
13 | Societies, Medical |
13 | Rheumatoid arthritis |
13 | Result |
13 | Residual |
13 | Primer |
13 | Pedigree |
13 | Pathogenesis |
13 | Ovary cancer |
13 | Online |
13 | Nutrition |
13 | Monthly notices |
13 | Monoclonal antibody |
13 | Microstructure |
13 | Malformation |
13 | Long term |
13 | Irwin |
13 | Important role |
13 | Immunology |
13 | Immunol |
13 | Heterozygote |
13 | Hemodialysis |
13 | Glucose |
13 | Gastroenterology |
13 | Evolution, Molecular |
13 | Dose |
13 | Data collection |
13 | Critical study |
13 | Colorectal cancer |
13 | Clinical Trials as Topic |
13 | Classification |
13 | Cdna |
13 | Cancer research |
13 | Bibliographic review |
13 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
12 | Urology |
12 | Stroke |
12 | Stellar population |
12 | Standard deviations |
12 | Significant differences |
12 | Signal Transduction |
12 | Seasonal variation |
12 | Research Design |
12 | Randomised |
12 | Predictive factor |
12 | Postmenopause |
12 | Phlebology |
12 | Phenotypic |
12 | Peptide |
12 | Pediatrics |
12 | Osteoarthritis |
12 | Nucl |
12 | National institutes |
12 | Mutation (genetics) |
12 | Multivariate Analysis |
12 | Magnetic Resonance Imaging |
12 | Late type stars |
12 | Instrumentation therapy |
12 | Human immunodeficiency virus |
12 | Homotransplantation |
12 | Heart rate |
12 | Gure |
12 | Guidelines as Topic |
12 | Genetic Loci |
12 | Environmental |
12 | Ecology letters |
12 | Drug |
12 | Detector |
12 | Dementia |
12 | Data sources |
12 | Cosmology |
12 | Cognitive |
12 | Clinical genetics |
12 | Climate |
12 | Cardiovascular |
12 | C-Onc gene |
12 | Body mass index |
12 | Atmos |
12 | Atherosclerosis |
12 | Astronomical catalogues |
12 | Animal |
12 | Angioplasty |
12 | Amino |
12 | Age of Onset |
11 | models |
11 | Ventricular |
11 | Validation |
11 | United States |
11 | Systematic errors |
11 | Stellar content |
11 | Spiral galaxies |
11 | Spectrometer |
11 | Sex Factors |
11 | Safety |
11 | Rotational |
11 | Research institute |
11 | Renal function |
11 | Registry |
11 | Quantitative Trait Loci |
11 | Prospective |
11 | Progression |
11 | Proc natl acad |
11 | Platelet |
11 | Photometric |
11 | Parameterization |
11 | Orbits |
11 | Ontario |
11 | Occupational exposure |
11 | Nutrient |
11 | Neoplasm Grading |
11 | National center |
11 | Myeloma |
11 | Morbidity |
11 | Mental retardation |
11 | Kidney disease |
11 | Immunohistochemistry |
11 | Gravity |
11 | Geol |
11 | Genome-Wide Association Study (methods) |
11 | Gene Expression Profiling |
11 | Galaxy halo |
11 | Forests |
11 | Elsevier science |
11 | Efficiency |
11 | Dose-Response Relationship, Drug |
11 | Definition |
11 | Databases, Genetic |
11 | DNA Mutational Analysis |
11 | Copyright |
11 | Constraint |
11 | Congestive heart failure |
11 | Colour |
11 | Body weight |
11 | Biomass |
11 | Biological sciences |
11 | Biogeography |
11 | Antiangiogenic agent |
11 | Abundance |
10 | Vaccine |
10 | Use |
10 | Univ |
10 | Typing |
10 | Type 2 diabetes |
10 | Timing |
10 | Therapy |
10 | Surface temperature |
10 | Substructure |
10 | Stakeholder |
10 | Spectrometry |
10 | Solar radiation |
10 | Small number |
10 | Rheum |
10 | Respiratory disease |
10 | Red stars |
10 | Psychiatry |
10 | Protooncogene |
10 | Prognostic |
10 | Primary |
10 | Predictor |
10 | Practice Guidelines as Topic (standards) |
10 | Physical parameter |
10 | Photon |
10 | Performance |
10 | Parkinson disease |
10 | Ovarian Neoplasms (pathology) |
10 | Other studies |
10 | Obesity |
10 | Norway |
10 | Node |
10 | Nephrology |
10 | National research council |
10 | Monoclonal |
10 | Metastatic |
10 | Metallicities |
10 | Meta-Analysis as Topic |
10 | Medical research |
Manipulations en shell (Unix/Dilib)
HfdCat /applis/lorexplor/Wicri/Asie/explor/AustralieFr.storage/AustralieFrV1.new/Data/Canada/Analysis/KwdEn.i.hfd| SxmlCut idx/l | grep ...
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |